Recent Insights » David Forster » The 21st Century Cures Act Easily Passed, But is it Good for Research Protection?
Other content in this Stream
Trend: Genetic Testing and Data Privacy Ownership
Understanding the Revised Common Rule
A Discussion of the Revised Common Rule - Jan 2017
Looking Ahead in 2018: Insights into Clinical Research Trends from Our Experts
In this paper, WCG thought-leaders provide insights on what they anticipate in 2018 in clinical trial technology, regulatory changes, and scientific developments.
Addressing the Challenges of Human Tissues and Cell Products Regulation
The 21st Century Cures Act: Implications for Human Subjects
Under the Microscope - Biomarker and Diagnostic Tests as FDA-Regulated Devices